{"product_id":"tirzepatide-peptide","title":"Tirzepatide Peptide | Dual Agonist Research","description":"\u003ch3 data-end=\"524\" data-start=\"454\"\u003eAdvanced Metabolic, Obesity \u0026amp; Insulin Sensitivity Research Peptide\u003c\/h3\u003e\n\u003cp data-end=\"659\" data-start=\"526\"\u003e\u003cstrong data-end=\"539\" data-start=\"526\"\u003eCategory:\u003c\/strong\u003e\u003cbr data-end=\"542\" data-start=\"539\"\u003eMetabolic Research • Obesity Biology • Endocrine Signaling • Insulin Resistance\u003c\/p\u003e\n\u003cp data-end=\"659\" data-start=\"526\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"695\" data-start=\"666\"\u003e\u003cstrong data-end=\"695\" data-start=\"669\"\u003eWhat Researchers Study\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"779\" data-start=\"696\"\u003eTirzepatide is a \u003cstrong data-end=\"748\" data-start=\"713\"\u003esynthetic dual-incretin peptide\u003c\/strong\u003e that simultaneously activates:\u003c\/p\u003e\n\u003cul data-end=\"895\" data-start=\"781\"\u003e\n\u003cli data-end=\"828\" data-start=\"781\"\u003e\n\u003cp data-end=\"828\" data-start=\"783\"\u003e\u003cstrong data-end=\"828\" data-start=\"783\"\u003eGLP-1 (Glucagon-Like Peptide-1) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"895\" data-start=\"829\"\u003e\n\u003cp data-end=\"895\" data-start=\"831\"\u003e\u003cstrong data-end=\"895\" data-start=\"831\"\u003eGIP (Glucose-Dependent Insulinotropic Polypeptide) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1047\" data-start=\"897\"\u003eThis dual mechanism allows researchers to study \u003cstrong data-end=\"980\" data-start=\"945\"\u003ecoordinated metabolic signaling\u003c\/strong\u003e, rather than isolated appetite suppression or insulin stimulation.\u003c\/p\u003e\n\u003cp data-end=\"1108\" data-start=\"1049\"\u003eTirzepatide is widely used as a \u003cstrong data-end=\"1103\" data-start=\"1081\"\u003ereference compound\u003c\/strong\u003e for:\u003c\/p\u003e\n\u003cul data-end=\"1330\" data-start=\"1109\"\u003e\n\u003cli data-end=\"1136\" data-start=\"1109\"\u003e\n\u003cp data-end=\"1136\" data-start=\"1111\"\u003eAdvanced obesity models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1181\" data-start=\"1137\"\u003e\n\u003cp data-end=\"1181\" data-start=\"1139\"\u003eInsulin resistance and diabetes research\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1215\" data-start=\"1182\"\u003e\n\u003cp data-end=\"1215\" data-start=\"1184\"\u003eFat vs lean mass partitioning\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1260\" data-start=\"1216\"\u003e\n\u003cp data-end=\"1260\" data-start=\"1218\"\u003eIncretin synergy and receptor cross-talk\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1330\" data-start=\"1261\"\u003e\n\u003cp data-end=\"1330\" data-start=\"1263\"\u003eComparative studies against GLP-1 mono-agonists (e.g., semaglutide)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"1375\" data-start=\"1337\"\u003e\u003cstrong data-end=\"1375\" data-start=\"1340\"\u003ePrimary Signal Pathways Studied\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"1623\" data-start=\"1377\"\u003e\n\u003cli data-end=\"1407\" data-start=\"1377\"\u003e\n\u003cp data-end=\"1407\" data-start=\"1379\"\u003e\u003cstrong data-end=\"1407\" data-start=\"1379\"\u003eGLP-1 receptor signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1436\" data-start=\"1408\"\u003e\n\u003cp data-end=\"1436\" data-start=\"1410\"\u003e\u003cstrong data-end=\"1436\" data-start=\"1410\"\u003eGIP receptor signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1478\" data-start=\"1437\"\u003e\n\u003cp data-end=\"1478\" data-start=\"1439\"\u003e\u003cstrong data-end=\"1478\" data-start=\"1439\"\u003ePancreatic β-cell insulin secretion\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1512\" data-start=\"1479\"\u003e\n\u003cp data-end=\"1512\" data-start=\"1481\"\u003e\u003cstrong data-end=\"1512\" data-start=\"1481\"\u003eCentral appetite regulation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1549\" data-start=\"1513\"\u003e\n\u003cp data-end=\"1549\" data-start=\"1515\"\u003e\u003cstrong data-end=\"1549\" data-start=\"1515\"\u003ePeripheral insulin sensitivity\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1587\" data-start=\"1550\"\u003e\n\u003cp data-end=\"1587\" data-start=\"1552\"\u003e\u003cstrong data-end=\"1587\" data-start=\"1552\"\u003eAdipocyte nutrient partitioning\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1623\" data-start=\"1588\"\u003e\n\u003cp data-end=\"1623\" data-start=\"1590\"\u003e\u003cstrong data-end=\"1623\" data-start=\"1590\"\u003eEnergy expenditure modulation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1727\" data-start=\"1625\"\u003eTirzepatide enables study of \u003cstrong data-end=\"1685\" data-start=\"1654\"\u003edual incretin amplification\u003c\/strong\u003e, not achievable with GLP-1-only peptides.\u003c\/p\u003e\n\u003cp data-end=\"1727\" data-start=\"1625\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"1778\" data-start=\"1734\"\u003e\u003cstrong data-end=\"1778\" data-start=\"1737\"\u003eWhy This Molecule Matters in Research\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"1924\" data-start=\"1779\"\u003eGLP-1 agonists reduce appetite — but often plateau.\u003cbr data-end=\"1833\" data-start=\"1830\"\u003eGIP alone can be obesogenic — but \u003cstrong data-end=\"1885\" data-start=\"1867\"\u003ein combination\u003c\/strong\u003e, it becomes metabolically synergistic.\u003c\/p\u003e\n\u003cp data-end=\"1956\" data-start=\"1926\"\u003eTirzepatide demonstrates that:\u003c\/p\u003e\n\u003cul data-end=\"2155\" data-start=\"1957\"\u003e\n\u003cli data-end=\"2002\" data-start=\"1957\"\u003e\n\u003cp data-end=\"2002\" data-start=\"1959\"\u003e\u003cstrong data-end=\"2002\" data-start=\"1959\"\u003eGIP signaling reprograms adipose tissue\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2045\" data-start=\"2003\"\u003e\n\u003cp data-end=\"2045\" data-start=\"2005\"\u003e\u003cstrong data-end=\"2045\" data-start=\"2005\"\u003eGLP-1 controls appetite and glycemia\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2155\" data-start=\"2046\"\u003e\n\u003cp data-end=\"2155\" data-start=\"2048\"\u003eTogether, they produce \u003cstrong data-end=\"2155\" data-start=\"2071\"\u003egreater fat loss, better insulin sensitivity, and improved metabolic flexibility\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2213\" data-start=\"2157\"\u003eThis makes tirzepatide a \u003cstrong data-end=\"2204\" data-start=\"2182\"\u003emechanistic bridge\u003c\/strong\u003e between:\u003c\/p\u003e\n\u003cul data-end=\"2302\" data-start=\"2214\"\u003e\n\u003cli data-end=\"2248\" data-start=\"2214\"\u003e\n\u003cp data-end=\"2248\" data-start=\"2216\"\u003eSemaglutide (GLP-1 mono-agonist)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2302\" data-start=\"2249\"\u003e\n\u003cp data-end=\"2302\" data-start=\"2251\"\u003eRetatrutide (GLP-1 + GIP + Glucagon triple agonist)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"2354\" data-start=\"2309\"\u003e\u003cstrong data-end=\"2354\" data-start=\"2312\"\u003eMechanism of Action (Research Context)\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-end=\"2374\" data-start=\"2356\"\u003e\u003cstrong data-end=\"2374\" data-start=\"2360\"\u003eGLP-1 Axis\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-end=\"2534\" data-start=\"2375\"\u003e\n\u003cli data-end=\"2423\" data-start=\"2375\"\u003e\n\u003cp data-end=\"2423\" data-start=\"2377\"\u003eEnhances glucose-dependent insulin secretion\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2468\" data-start=\"2424\"\u003e\n\u003cp data-end=\"2468\" data-start=\"2426\"\u003eSuppresses glucagon during hyperglycemia\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2495\" data-start=\"2469\"\u003e\n\u003cp data-end=\"2495\" data-start=\"2471\"\u003eSlows gastric emptying\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2534\" data-start=\"2496\"\u003e\n\u003cp data-end=\"2534\" data-start=\"2498\"\u003eReduces central appetite signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"2552\" data-start=\"2536\"\u003e\u003cstrong data-end=\"2552\" data-start=\"2540\"\u003eGIP Axis\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-end=\"2713\" data-start=\"2553\"\u003e\n\u003cli data-end=\"2603\" data-start=\"2553\"\u003e\n\u003cp data-end=\"2603\" data-start=\"2555\"\u003eImproves insulin sensitivity in adipose tissue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2643\" data-start=\"2604\"\u003e\n\u003cp data-end=\"2643\" data-start=\"2606\"\u003eEnhances nutrient uptake efficiency\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2682\" data-start=\"2644\"\u003e\n\u003cp data-end=\"2682\" data-start=\"2646\"\u003eModulates fat storage vs oxidation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2713\" data-start=\"2683\"\u003e\n\u003cp data-end=\"2713\" data-start=\"2685\"\u003eAlters adipokine signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"2738\" data-start=\"2715\"\u003e\u003cstrong data-end=\"2738\" data-start=\"2719\"\u003eCombined Effect\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-end=\"2908\" data-start=\"2739\"\u003e\n\u003cli data-end=\"2793\" data-start=\"2739\"\u003e\n\u003cp data-end=\"2793\" data-start=\"2741\"\u003eGreater \u003cstrong data-end=\"2774\" data-start=\"2749\"\u003ebody weight reduction\u003c\/strong\u003e than GLP-1 alone\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2849\" data-start=\"2794\"\u003e\n\u003cp data-end=\"2849\" data-start=\"2796\"\u003eSuperior \u003cstrong data-end=\"2847\" data-start=\"2805\"\u003eHbA1c and insulin sensitivity outcomes\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2908\" data-start=\"2850\"\u003e\n\u003cp data-end=\"2908\" data-start=\"2852\"\u003eImproved \u003cstrong data-end=\"2887\" data-start=\"2861\"\u003efat-to-lean mass ratio\u003c\/strong\u003e during weight loss\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"2942\" data-start=\"2915\"\u003e\u003cstrong data-end=\"2942\" data-start=\"2918\"\u003eKey Research Domains\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-end=\"2990\" data-start=\"2944\"\u003e\u003cstrong data-end=\"2990\" data-start=\"2948\"\u003e1. Obesity \u0026amp; Body Composition Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3029\" data-start=\"2991\"\u003eTirzepatide consistently demonstrates:\u003c\/p\u003e\n\u003cul data-end=\"3165\" data-start=\"3030\"\u003e\n\u003cli data-end=\"3089\" data-start=\"3030\"\u003e\n\u003cp data-end=\"3089\" data-start=\"3032\"\u003eGreater total weight reduction than GLP-1 mono-agonists\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3127\" data-start=\"3090\"\u003e\n\u003cp data-end=\"3127\" data-start=\"3092\"\u003ePreferential loss of \u003cstrong data-end=\"3125\" data-start=\"3113\"\u003efat mass\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3165\" data-start=\"3128\"\u003e\n\u003cp data-end=\"3165\" data-start=\"3130\"\u003eBetter \u003cstrong data-end=\"3163\" data-start=\"3137\"\u003elean mass preservation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3281\" data-start=\"3167\"\u003eResearchers frequently use tirzepatide as a \u003cstrong data-end=\"3233\" data-start=\"3211\"\u003econtrol comparator\u003c\/strong\u003e in next-generation obesity peptide development.\u003c\/p\u003e\n\u003ch3 data-end=\"3336\" data-start=\"3288\"\u003e\u003cstrong data-end=\"3336\" data-start=\"3292\"\u003e2. Insulin Resistance \u0026amp; Glycemic Control\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3364\" data-start=\"3337\"\u003eTirzepatide is studied for:\u003c\/p\u003e\n\u003cul data-end=\"3526\" data-start=\"3365\"\u003e\n\u003cli data-end=\"3413\" data-start=\"3365\"\u003e\n\u003cp data-end=\"3413\" data-start=\"3367\"\u003eEnhanced insulin secretion (glucose-dependent)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3455\" data-start=\"3414\"\u003e\n\u003cp data-end=\"3455\" data-start=\"3416\"\u003eImproved peripheral insulin sensitivity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3493\" data-start=\"3456\"\u003e\n\u003cp data-end=\"3493\" data-start=\"3458\"\u003eReduced fasting glucose and HOMA-IR\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3526\" data-start=\"3494\"\u003e\n\u003cp data-end=\"3526\" data-start=\"3496\"\u003eβ-cell functional preservation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3613\" data-start=\"3528\"\u003eIts dual incretin action allows deeper study of \u003cstrong data-end=\"3612\" data-start=\"3576\"\u003epancreatic–adipose communication\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-end=\"3657\" data-start=\"3620\"\u003e\u003cstrong data-end=\"3657\" data-start=\"3624\"\u003e3. Lipid \u0026amp; Hepatic Metabolism\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3692\" data-start=\"3658\"\u003eObserved research effects include:\u003c\/p\u003e\n\u003cul data-end=\"3831\" data-start=\"3693\"\u003e\n\u003cli data-end=\"3716\" data-start=\"3693\"\u003e\n\u003cp data-end=\"3716\" data-start=\"3695\"\u003eReduced triglycerides\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3744\" data-start=\"3717\"\u003e\n\u003cp data-end=\"3744\" data-start=\"3719\"\u003eImproved LDL \/ HDL ratios\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3781\" data-start=\"3745\"\u003e\n\u003cp data-end=\"3781\" data-start=\"3747\"\u003eDecreased hepatic fat accumulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3831\" data-start=\"3782\"\u003e\n\u003cp data-end=\"3831\" data-start=\"3784\"\u003eImproved markers of NAFLD\/NASH in animal models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"3878\" data-start=\"3838\"\u003e\u003cstrong data-end=\"3878\" data-start=\"3842\"\u003e4. Comparative Incretin Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3922\" data-start=\"3879\"\u003eTirzepatide is frequently compared against:\u003c\/p\u003e\n\u003cul data-end=\"3994\" data-start=\"3923\"\u003e\n\u003cli data-end=\"3949\" data-start=\"3923\"\u003e\n\u003cp data-end=\"3949\" data-start=\"3925\"\u003eSemaglutide (GLP-1 only)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3963\" data-start=\"3950\"\u003e\n\u003cp data-end=\"3963\" data-start=\"3952\"\u003eLiraglutide\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3994\" data-start=\"3964\"\u003e\n\u003cp data-end=\"3994\" data-start=\"3966\"\u003eRetatrutide (triple agonist)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"4072\" data-start=\"3996\"\u003eThis positions it as a \u003cstrong data-end=\"4040\" data-start=\"4019\"\u003ebenchmark peptide\u003c\/strong\u003e in metabolic signaling studies.\u003c\/p\u003e\n\u003cp data-end=\"4072\" data-start=\"3996\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"4117\" data-start=\"4079\"\u003e\u003cstrong data-end=\"4117\" data-start=\"4082\"\u003eResearch Application Guidelines\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cblockquote data-end=\"4187\" data-start=\"4118\"\u003e\n\u003cp data-end=\"4187\" data-start=\"4120\"\u003e\u003cem data-end=\"4187\" data-start=\"4120\"\u003eFor experimental planning only — not for human or veterinary use.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"4569\" data-start=\"4189\"\u003e\n\u003cthead data-end=\"4245\" data-start=\"4189\"\u003e\n\u003ctr data-end=\"4245\" data-start=\"4189\"\u003e\n\u003cth class=\"\" data-col-size=\"sm\" data-end=\"4206\" data-start=\"4189\"\u003eResearch Model\u003c\/th\u003e\n\u003cth class=\"\" data-col-size=\"sm\" data-end=\"4222\" data-start=\"4206\"\u003eTypical Range\u003c\/th\u003e\n\u003cth class=\"\" data-col-size=\"sm\" data-end=\"4230\" data-start=\"4222\"\u003eRoute\u003c\/th\u003e\n\u003cth class=\"\" data-col-size=\"sm\" data-end=\"4245\" data-start=\"4230\"\u003eStudy Focus\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"4569\" data-start=\"4264\"\u003e\n\u003ctr data-end=\"4338\" data-start=\"4264\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4275\" data-start=\"4264\"\u003eIn-vitro\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4286\" data-start=\"4275\"\u003e1–100 nM\u003c\/td\u003e\n\u003ctd data-end=\"4299\" data-start=\"4286\" data-col-size=\"sm\"\u003eCell media\u003c\/td\u003e\n\u003ctd data-end=\"4338\" data-start=\"4299\" data-col-size=\"sm\"\u003eReceptor binding, insulin signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4416\" data-start=\"4339\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4355\" data-start=\"4339\"\u003eRodent models\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4371\" data-start=\"4355\"\u003e0.1–0.5 mg\/kg\u003c\/td\u003e\n\u003ctd data-end=\"4376\" data-start=\"4371\" data-col-size=\"sm\"\u003eSC\u003c\/td\u003e\n\u003ctd data-end=\"4416\" data-start=\"4376\" data-col-size=\"sm\"\u003eWeight, glucose, insulin sensitivity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4495\" data-start=\"4417\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4434\" data-start=\"4417\"\u003ePrimate models\u003c\/td\u003e\n\u003ctd data-end=\"4452\" data-start=\"4434\" data-col-size=\"sm\"\u003e0.05–0.15 mg\/kg\u003c\/td\u003e\n\u003ctd data-end=\"4457\" data-start=\"4452\" data-col-size=\"sm\"\u003eSC\u003c\/td\u003e\n\u003ctd data-end=\"4495\" data-start=\"4457\" data-col-size=\"sm\"\u003eBody composition, glycemic control\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4569\" data-start=\"4496\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4514\" data-start=\"4496\"\u003eChronic studies\u003c\/td\u003e\n\u003ctd data-end=\"4530\" data-start=\"4514\" data-col-size=\"sm\"\u003eWeekly dosing\u003c\/td\u003e\n\u003ctd data-end=\"4535\" data-start=\"4530\" data-col-size=\"sm\"\u003eSC\u003c\/td\u003e\n\u003ctd data-end=\"4569\" data-start=\"4535\" data-col-size=\"sm\"\u003eLong-term metabolic adaptation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"4871\" data-start=\"4842\"\u003e\u003cstrong data-end=\"4871\" data-start=\"4845\"\u003eProduct Specifications\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"5200\" data-start=\"4873\"\u003e\n\u003cli data-end=\"4907\" data-start=\"4873\"\u003e\n\u003cp data-end=\"4907\" data-start=\"4875\"\u003e\u003cstrong data-end=\"4893\" data-start=\"4875\"\u003eCompound Name:\u003c\/strong\u003e Tirzepatide\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4944\" data-start=\"4908\"\u003e\n\u003cp data-end=\"4944\" data-start=\"4910\"\u003e\u003cstrong data-end=\"4925\" data-start=\"4910\"\u003eCAS Number:\u003c\/strong\u003e 2023788-19-2\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4990\" data-start=\"4945\"\u003e\n\u003cp data-end=\"4990\" data-start=\"4947\"\u003e\u003cstrong data-end=\"4969\" data-start=\"4947\"\u003eMolecular Formula:\u003c\/strong\u003e C₂₂₅H₃₄₈N₄₈O₆₈\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5031\" data-start=\"4991\"\u003e\n\u003cp data-end=\"5031\" data-start=\"4993\"\u003e\u003cstrong data-end=\"5014\" data-start=\"4993\"\u003eMolecular Weight:\u003c\/strong\u003e 4,813.53 Da\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5085\" data-start=\"5032\"\u003e\n\u003cp data-end=\"5085\" data-start=\"5034\"\u003e\u003cstrong data-end=\"5052\" data-start=\"5034\"\u003ePeptide Class:\u003c\/strong\u003e Dual incretin receptor agonist\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5122\" data-start=\"5086\"\u003e\n\u003cp data-end=\"5122\" data-start=\"5088\"\u003e\u003cstrong data-end=\"5099\" data-start=\"5088\"\u003ePurity:\u003c\/strong\u003e ≥98% (HPLC verified)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5155\" data-start=\"5123\"\u003e\n\u003cp data-end=\"5155\" data-start=\"5125\"\u003e\u003cstrong data-end=\"5134\" data-start=\"5125\"\u003eForm:\u003c\/strong\u003e Lyophilized powder\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5200\" data-start=\"5156\"\u003e\n\u003cp data-end=\"5200\" data-start=\"5158\"\u003e\u003cstrong data-end=\"5173\" data-start=\"5158\"\u003eAppearance:\u003c\/strong\u003e White to off-white solid\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-start=\"598\" data-end=\"638\"\u003e\u003cstrong data-start=\"598\" data-end=\"636\"\u003eBatch Documentation \u0026amp; Traceability\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"645\" data-end=\"762\"\u003eEach vial is shipped with a \u003cstrong data-start=\"673\" data-end=\"697\"\u003elot-specific QR code\u003c\/strong\u003e that provides secure access to batch documentation, including:\u003c\/p\u003e\n\u003cp data-start=\"769\" data-end=\"891\"\u003e• Certificate of Analysis (COA)\u003cbr data-start=\"800\" data-end=\"803\"\u003e• Identity verification report (HPLC \/ MS)\u003cbr data-start=\"847\" data-end=\"850\"\u003e• Lot number, potency, and expiration\u003c\/p\u003e\n\u003cp data-start=\"898\" data-end=\"1028\"\u003eDocumentation is \u003cstrong data-start=\"915\" data-end=\"955\"\u003elocked to the specific batch shipped\u003c\/strong\u003e to ensure traceability, version control, and research reproducibility.\u003c\/p\u003e\n\u003cp data-start=\"1035\" data-end=\"1113\"\u003eQR access is provided with the physical product and is not reused across lots.\u003c\/p\u003e\n\u003cp data-start=\"1035\" data-end=\"1113\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"5945\" data-start=\"5915\"\u003e\u003cstrong data-end=\"5945\" data-start=\"5918\"\u003eResearch Use Disclaimer\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"6080\" data-start=\"5946\"\u003eThis product is supplied \u003cstrong data-end=\"6011\" data-start=\"5971\"\u003estrictly for laboratory research use\u003c\/strong\u003e.\u003cbr data-end=\"6015\" data-start=\"6012\"\u003eNot for human or veterinary consumption, diagnosis, or treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Velora Biolabs","offers":[{"title":"10 mg vial","offer_id":47055892480154,"sku":"VBL-TR-RS-010","price":69.0,"currency_code":"USD","in_stock":true},{"title":"30 mg vial","offer_id":47055892906138,"sku":"VBL-TR-RS-030","price":129.0,"currency_code":"USD","in_stock":true},{"title":"60 mg vial","offer_id":47055892938906,"sku":"VBL-TR-RS-060","price":229.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0719\/1484\/8410\/files\/TR60.png?v=1782680156","url":"https:\/\/velorabiolabs.com\/products\/tirzepatide-peptide","provider":"Velora Biolabs","version":"1.0","type":"link"}